Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

RSS icon
Medtronic has received U.S. Food and Drug Administration (FDA) clearance for its new InPen smartphone app and announced the launch of its new Smart MDI system. Smart MDI was designed to provide real-time insights for users on multiple daily injection (MDI) therapy. It includes the InPen smart insulin pen, the InPen app and Medtronic’s disposable, all-in-one Simplera continuous glucose monitor (CGM), which received U.S. Food and Drug Administration approval back in August.

Medtronic receives key FDA clearance, launches new diabetes system

Medtronic designed its new Smart MDI system to provide real-time insights to users on multiple daily injection therapy.

Abbott FreeStyle Libre 3 CGM

Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment

Abbott expects the new facility to produce more FreeStyle Libre 3 sensors than anywhere else in the world.

Predicting sudden cardiac death after a heart attack may be impossible—for now

Researchers tried to crack the code, but they fell short time and time again. AI may offer potential as one way to finally find an answer, they added. 

Massachusetts Institute of Technology won a $50,000 award to help commercialize its 3D printed, polymeric auxetic stent to treat pediatric aortic coarctation. It is bioresorbable so the patient can continue to grow without the need for as many reinterventions.

Pediatric cardiology device competition introduces world to new technologies

Most cardiac devices do not fit young children, making it especially important for growth in pediatric cardiology to continue. The FDA helped fund a contest aimed at identifying new devices that show a ton of potential. 

https://www.dynocardia.care/

NIH awards commercialization grant for wrist-worn continuous ICU-grade blood pressure monitor

Dynocardia has now received nearly $5.1 million in funding from the NHLBI to help speed commercializing its wrist-worn monitor to avoid the need for invasive catheter BP monitoring.

Monitoring acute heart patients at home linked to considerable cost savings

The new report could go on to help guide decisions made by CMS and hospital leadership teams for years to come.

cardiologists evaluating the human heart to provide a treatment strategy

Rising heart failure, AFib rates a ‘wake-up call’ for US cardiologists

Today's heart teams already face a number of challenges on a day-to-day basis.  New data suggest they could soon be treating more patients than ever before.  

Endotronix, an Illinois-based healthcare technology company, has gained U.S. Food and Drug Administration approval for its Cordella Pulmonary Artery (PA) Sensor System, which uses PA pressure-guided therapy to manage and treat heart failure patients.

Implantable PA sensor for heart failure linked to positive 1-year outcomes

The new Cordella device from Endotronix, now an Edwards Lifesciences company, uses an implantable device to track the patient's pulmonary artery pressure and other helpful health data.

Displaying 1 - 8 of 106
Design by Adaptive Theme